Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy

Rana, D. (2021) Cost utility analysis of the FEMME trial reports uterine artery embolization as not cost-effective over myomectomy. Interventional News, 83, p. 11.

[img] Text
258208.pdf - Accepted Version

230kB

Publisher's URL: https://interventionalnews.com/interventional-news-issue-83-september-2021-edition/

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Rana, Miss Dikshyanta
Authors: Rana, D.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment
Journal Name:Interventional News
Publisher:BIBA Publishing
Copyright Holders:Copyright © 2021 BIBA Publishing
First Published:First published in Interventional News 83:11
Publisher Policy:Reproduced with the permission of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record